Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 57 min ago
PreprintCC BY-NC-NDbioRxiv

Machine Learning for Toxicity Prediction in Low-Sample Molecular Classes

  1. 1Johns Hopkins Applied Physics Laboratory

Abstract

Deep learning models such as Chemprop have advanced quantitative molecular property prediction, but their reliance on large training sets limits use in data-scarce domains. We propose a framework that fine-tunes a general baseline model trained on publicly available data on small, class-specific datasets. The resulting models retain the baseline's generalization ability while gaining class-specific accuracy and produce probabilistic outputs that capture uncertainty in the training data. We demonstrate the approach on three toxicity classes defined by a common core structure, target, or mode of action: (i) organophosphates, (ii) androgen receptor antagonists, and (iii) estrogen receptor beta antagonists. Each fine-tuned model outperforms classical machine-learning methods and the EPA TEST tool. The probabilistic nature of the predictions enables prioritization of compounds for experimental validation and seamless integration with data streams of varying quality, supporting iterative decision-making in chemical safety and drug discovery.

Related

  1. A comparative analysis of graph neural networks and classical machine learning for carbapenem-resistance prediction and genomic interpretation in Acinetobacter baumannii
    Irfan Sharif Shaik, Morteza Sarmadi
    Frontiers in bioinformaticsPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  2. A novel LLM-based GPT-neo transformer with machine learning architecture for promoters prediction in Agrobacterium
    Nagwan Abdel Samee, Rawan Talaat, Ali Raza +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  3. Breath molecular feature profiling with machine learning for noninvasive diagnosis of gout: a single-center case-control study
    Zebin Cai, Xin Huang, Xuao Luo +3
    Frontiers in molecular biosciencesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  4. Immune-related molecular links between asthma and Alzheimer’s disease identified by multi-omics, machine learning and single-cell analysis
    Li-jie Yang, Ni-shan Deng, Miao-juan Zhu +3
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  5. A Two-Stage ESM-Based Machine Learning Pipeline for Robust Hierarchically Evaluated Enzyme Function Prediction
    Xiao Hua, Ghjuvan M Grimaud
    Computational and structural biotechnology journalPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCEurope PMCPMC
BibTeX
@misc{barajas2026machine,
  title = {{Machine Learning for Toxicity Prediction in Low-Sample Molecular Classes}},
  author = {C. Barajas and L. Dunphy and L. Mullany and O. Tiburzi and E. Lloyd},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.16.751426},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.16.751426v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Machine Learning for Toxicity Prediction in Low-Sample Molecular Classes
AU  - C. Barajas
AU  - L. Dunphy
AU  - L. Mullany
AU  - O. Tiburzi
AU  - E. Lloyd
PY  - 2026
DA  - 2026/09/16
PB  - bioRxiv
DO  - 10.64898/2026.09.16.751426
UR  - https://www.biorxiv.org/content/10.64898/2026.09.16.751426v1
AB  - Deep learning models such as Chemprop have advanced quantitative molecular property prediction, but their reliance on large training sets limits use in data-scarce domains. We propose a framework that fine-tunes a general baseline model trained on publicly available data on small, class-specific datasets. The resulting models retain the baseline's generalization ability while gaining class-specific accuracy and produce probabilistic outputs that capture uncertainty in the training data. We demonstrate the approach on three toxicity classes defined by a common core structure, target, or mode of action: (i) organophosphates, (ii) androgen receptor antagonists, and (iii) estrogen receptor beta antagonists. Each fine-tuned model outperforms classical machine-learning methods and the EPA TEST tool. The probabilistic nature of the predictions enables prioritization of compounds for experimental validation and seamless integration with data streams of varying quality, supporting iterative decision-making in chemical safety and drug discovery.
ER  -